Volume 25, Issue 6 (Monthly-Aug 2014)                   J Urmia Univ Med Sci 2014, 25(6): 502-510 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rezaeiani S, Ebrahimi F, Honari H, Hajizade A, Barati B. CLONING AND EXPRESSION OF CLOSTRIDIUM BOTULINUM TYPE B BINDING DOMAIN E. COLI. J Urmia Univ Med Sci. 2014; 25 (6) :502-510
URL: http://umj.umsu.ac.ir/article-1-2366-en.html
Department of Biology, Imam Hossein University , febrhimi@ihu.ac.ir
Abstract:   (5032 Views)


 Backgrounds & Aims: Botulism is caused by botulinum toxin. The best way to avoid the neurotoxin syndrome caused by BONT/B is to use recombinant vaccine made of BONT/B binding domain because binding domain has sufficient epitops to stimulate immune response.

 Materials & Methods: Initially BONT/B binding domain gene sequence were obtained from GenBank. Then the primers were designed. PCR reaction was performed. Then gene was ligated to pGEM-Teasy vactor. After verifying the transformation E.coli DH 5 α , subcloning was done. Pet28(a)+ vector was introduced to SDS-PAGE and Western blot confirmed production of the protein.

 Results: The results obtained from PCR sequencing via IPTG induction and expression analysis by SDS-PAGE and its confirmation by Western blot indicated the cloning and expression process accuracy.

 Conclusion: Finally, this method may be suitable for production of recombinant vaccines without any side effects. Cloning and expression of this vaccine candidate were conducted successfully and its immunization potential should be investigated.


  SOURCE: URMIA MED J 2014: 25(6): 510 ISSN: 1027-3727

Full-Text [PDF 312 kb]   (984 Downloads)    
Type of Study: Research | Subject: آناتومی

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | URMIA MEDICAL JOURNAL

Designed & Developed by : Yektaweb